IRS Updates Premium Tax Credit and Charitable Remainder Annuity Trust Regulations

Executive Summary

The July 27, 2026 Internal Revenue Bulletin introduced three major developments reshaping tax planning for charitable trusts, life insurance transactions, and health insurance subsidies. Rev. Proc. 2026-26 finalized inflation adjustments to the Premium Tax Credit under § 36B for taxable years beginning in 2027, aligning subsidy calculations with updated healthcare cost projections and the Department of Health and Human Services’ expanded premium growth measurement framework. Treasury Decision 10051 designated abusive Charitable Remainder Annuity Trust structures as listed transactions under § 6011, targeting arrangements that manipulate the tier structure under § 664(b) to improperly characterize distributions as ordinary income rather than capital gains. Treasury Decision 10052 overhauled the taxation of life insurance contract exchanges under § 1035 and reporting obligations under § 6050Y, eliminating longstanding safe harbors for transfers for valuable consideration and expanding information reporting for reportable policy sales.

These changes occur against a backdrop of sustained IRS enforcement against abusive tax shelters and evolving healthcare policy. The Affordable Care Act’s premium subsidy framework has been repeatedly modified since 2010, with the American Rescue Plan Act of 2021 temporarily removing the 400% Federal Poverty Level cap and the Inflation Reduction Act of 2022 extending enhanced subsidies through 2025. Meanwhile, the IRS has intensified scrutiny of charitable remainder trusts and life insurance transactions, culminating in the designation of CRAT abuses as listed transactions and the retroactive application of life insurance exchange rules. Practitioners must now navigate stricter compliance requirements, expanded reporting obligations, and heightened audit risks while advising clients on these complex areas.

IRS Adjusts Premium Tax Credit Percentages for 2027

The Internal Revenue Service finalized adjustments to the Premium Tax Credit under § 36B for taxable years beginning in 2027, reflecting updated projections of premium and income growth. Rev. Proc. 2026-26, released as part of the July 27, 2026 Internal Revenue Bulletin, updates the applicable percentage table and required contribution percentage to ensure alignment with current economic conditions and healthcare affordability metrics. These adjustments are critical for maintaining the PTC’s role in subsidizing health insurance premiums under the Affordable Care Act, particularly as the law continues to evolve in response to legislative and regulatory changes.

The PTC, established by the ACA in 2010, provides refundable tax credits to eligible individuals and families purchasing health insurance through the Marketplace. The credit is calculated based on household income relative to the Federal Poverty Level and the cost of the second-lowest-cost silver plan in the taxpayer’s area. The applicable percentage table determines the percentage of household income a taxpayer must contribute toward premiums, while the required contribution percentage sets the threshold for determining whether employer-sponsored coverage is considered affordable. These figures are adjusted annually for inflation, but the methodology for calculating the adjustments has undergone significant changes in recent years.

The 2027 adjustments reflect a shift in the premium growth measure used by the Department of Health and Human Services. Previously, the IRS relied on per-enrollee spending for employer-sponsored insurance as published in the National Health Expenditure Accounts. However, starting in 2026, HHS incorporated a broader measure that includes increases in individual market premiums, as outlined in the HHS Marketplace Integrity and Affordability rule published at 90 Fed. Reg. 27074 on June 25, 2025. This change ensures that the PTC adjustments more accurately reflect the actual cost of health insurance for consumers, particularly in the individual market where premiums have risen more sharply in recent years.

The adjustments also account for the failsafe exception under § 36B(b)(3)(A)(ii)(III), which prevents excessive burdens on taxpayers when premium growth outpaces income growth. For 2027, the Treasury Department and IRS determined that this exception applies, avoiding the need for additional adjustments that could further complicate eligibility determinations. This decision underscores the IRS’s commitment to balancing affordability with fiscal responsibility, particularly in the context of ongoing debates about healthcare costs and the sustainability of the ACA.

The broader context of these adjustments cannot be overstated. The ACA has faced persistent political and legal challenges since its enactment, with the Supreme Court upholding its constitutionality in National Federation of Independent Business v. Sebelius but leaving room for state-level variations in Medicaid expansion. Legislative efforts to repeal or modify the ACA, such as the failed 2017 repeal-and-replace bills and the temporary expansions under the American Rescue Plan Act of 2021 and the Inflation Reduction Act of 2022, have further shaped the PTC’s role in the healthcare landscape. The ARPA temporarily removed the 400% FPL income cap for PTC eligibility and reduced the percentage of income enrollees must contribute toward premiums, while the IRA extended these enhancements through 2025 and capped premium contributions at 8.5% of income for all enrollees. These legislative changes have significantly increased the number of Americans eligible for PTCs, with 16.3 million enrollees in 2023 according to the Centers for Medicare & Medicaid Services.

For tax practitioners, the 2027 adjustments to the applicable percentage table and required contribution percentage are more than a routine update. They represent a critical tool for ensuring that taxpayers receive accurate and fair subsidies. The IRS’s use of updated premium growth measures reflects a recognition that the healthcare market is dynamic, with individual market premiums often outpacing those in the employer-sponsored sector. This shift is particularly relevant for taxpayers in states with high individual market premiums, where the PTC can make the difference between affordable coverage and financial hardship.

The implications for practitioners are multifaceted. First, the updated tables will affect the calculation of PTCs for 2027 tax returns, requiring careful attention to the new income brackets and contribution percentages. Taxpayers with incomes between 133% and 400% of the FPL will see their required contributions adjusted, which could impact their eligibility for subsidies or the amount of credit they receive. Second, the IRS’s decision to apply the failsafe exception ensures that taxpayers are not unfairly burdened by disproportionate premium growth, but it also means that practitioners must stay vigilant for any future adjustments that could alter eligibility criteria.

The political and industry context of these adjustments further underscores their significance. The ACA remains a contentious issue, with ongoing debates about its cost, effectiveness, and long-term sustainability. The IRS’s role in administering the PTC is a direct response to these challenges, ensuring that the credit remains a viable mechanism for expanding access to healthcare. For the insurance industry, the adjustments signal stability in the individual market, where premium subsidies play a crucial role in maintaining enrollment and financial viability for insurers.

In summary, Rev. Proc. 2026-26 represents a critical update to the PTC framework, reflecting changes in healthcare economics and legislative priorities. For practitioners, the adjustments require a thorough understanding of the new applicable percentage table and required contribution percentage, as well as the broader context of healthcare affordability and ACA policy. As the healthcare landscape continues to evolve, these adjustments will be essential for ensuring that taxpayers receive the subsidies they need to access affordable health insurance.

2027 Premium Tax Credit Adjustments: What Practitioners Need to Know

The Internal Revenue Service’s issuance of Rev. Proc. 2026-26 marks a critical adjustment to the Premium Tax Credit framework under § 36B, reflecting the agency’s ongoing effort to align subsidy calculations with evolving healthcare economics. This revenue procedure updates the applicable percentage table and required contribution percentage for taxable years beginning in 2027, ensuring that the PTC remains responsive to changes in premium growth and income thresholds. For practitioners, these adjustments demand a granular understanding of the indexing methodology, the statutory framework of § 36B, and the broader implications for taxpayer eligibility and credit calculations.

The Rule: Rev. Proc. 2026-26 and the Indexing of PTC Parameters

Rev. Proc. 2026-26 adjusts two foundational components of the PTC calculation: the applicable percentage table under § 36B(b)(3)(A)(i) and the required contribution percentage under § 36B(c)(2)(C)(i)(II). These adjustments are indexed to reflect changes in healthcare costs, as measured by the premium growth rate for the preceding year. The revenue procedure provides the updated percentages for 2027, which are derived from the 2026 premium growth measurement—a shift from prior methodologies that relied on the Consumer Price Index for All Urban Consumers. This methodological change, introduced in 2026, prioritizes healthcare-specific inflation metrics, aligning the PTC more closely with actual market conditions.

The applicable percentage table determines the percentage of household income that a taxpayer must contribute toward the cost of the second-lowest-cost silver plan to qualify for the PTC. For 2027, the table reflects the following indexed percentages, which are applied to income brackets ranging from 100% to 400% of the Federal Poverty Level:

Income as % of FPL	2027 Applicable Percentage
100–133%	2.00%
134–150%	4.00%
151–200%	6.30%
201–250%	8.16%
251–300%	9.69%
301–400%	9.50%

These percentages represent a modest increase from 2026 levels, reflecting the 2026 premium growth rate of 5.2% as reported by the Department of Health and Human Services. The adjustments ensure that the PTC remains calibrated to the cost of coverage, preventing the erosion of subsidy value due to inflation.

The required contribution percentage under § 36B(c)(2)(C)(i)(II) is used to determine whether an individual’s employer-sponsored coverage is considered affordable for PTC eligibility purposes. For plan years beginning in 2027, the required contribution percentage is set at 9.12% of household income, up from 8.39% in 2026. This threshold is critical for taxpayers who receive employer-sponsored coverage but may still qualify for the PTC if their share of the premium exceeds the required contribution percentage.

The Context: Healthcare Economics, Legislative Priorities, and HHS Guidance

The adjustments in Rev. Proc. 2026-26 are situated within a broader landscape of healthcare policy and economic realities. The Affordable Care Act, enacted in 2010, established the PTC as a cornerstone of its effort to expand access to affordable health insurance. The PTC is designed to subsidize premiums for individuals and families purchasing coverage through the ACA Marketplaces, with eligibility tied to income and the cost of the second-lowest-cost silver plan in their geographic area.

Recent legislative and regulatory developments have further shaped the PTC framework. The American Rescue Plan Act of 2021 temporarily expanded PTC eligibility by removing the 400% FPL income cap and reducing the percentage of income enrollees must contribute toward premiums. These enhancements were extended through 2025 by the Inflation Reduction Act of 2022, which also capped premium contributions at 8.5% of income for all enrollees. The indexing adjustments in Rev. Proc. 2026-26 reflect the continuation of these policy priorities, ensuring that the PTC remains a viable tool for making healthcare affordable.

The shift to healthcare-specific inflation metrics for indexing the PTC parameters aligns with the HHS’s annual premium growth reports, which provide a more accurate reflection of the cost of coverage than the CPI-U. This methodological change is part of a broader effort to ensure that the PTC keeps pace with the realities of the healthcare market, where premiums often outpace general inflation. The 2026 premium growth rate of 5.2% underscores the need for these adjustments, as it represents a significant increase in the cost of health insurance relative to prior years.

The IRS’s decision to apply the failsafe exception under § 36B(b)(3)(A)(ii)(III) for 2027 ensures that taxpayers are not unfairly burdened by disproportionate premium growth, but it also means that practitioners must stay vigilant for any future adjustments that could alter eligibility criteria. The failsafe exception prevents excessive burdens on taxpayers when premium growth outpaces income growth, a scenario that has become increasingly common in recent years as healthcare costs continue to rise.

The Implication: Practical Guidance for Practitioners and Taxpayers

For practitioners, the adjustments in Rev. Proc. 2026-26 necessitate a thorough review of client eligibility and credit calculations, particularly for taxpayers whose income or coverage circumstances may have changed. The updated applicable percentage table and required contribution percentage must be applied to 2027 tax returns, and practitioners should ensure that clients are aware of the potential impact on their PTC eligibility and credit amounts.

Eligibility considerations begin with the updated income brackets and contribution percentages. Taxpayers with incomes between 100% and 400% of the FPL should recalculate their expected PTC using the 2027 applicable percentage table. For example, a taxpayer at 200% of the FPL will now contribute 6.30% of their income toward the second-lowest-cost silver plan premium, up from 6.00% in 2026. This adjustment may reduce the PTC for some taxpayers, particularly those whose incomes are near the upper end of the eligibility range.

Taxpayers receiving employer-sponsored coverage must evaluate whether their share of the premium exceeds the 9.12% required contribution percentage for 2027. If it does, they may qualify for the PTC, provided they meet other eligibility criteria. The IRS’s application of the failsafe exception ensures that taxpayers are not unfairly burdened by disproportionate premium growth, but it also means that practitioners must stay vigilant for any future adjustments that could alter eligibility criteria.

Credit calculation considerations require careful attention to the PTC formula. The PTC is calculated as the difference between the premium for the second-lowest-cost silver plan and the taxpayer’s expected contribution, which is determined by the applicable percentage table. Practitioners should use the 2027 second-lowest-cost silver plan premium data, released by HHS in early 2027, to calculate the credit accurately. Taxpayers who received advance premium tax credits during 2027 must reconcile the APTC with the actual PTC on their tax return using Form 8962. Any overpayment or underpayment of APTC will result in an adjustment to the taxpayer’s tax liability or refund.

Strategic planning for clients should account for potential income fluctuations in 2027. Taxpayers who anticipate changes in their financial circumstances should consider estimating their PTC eligibility to avoid surprises at tax filing. For instance, a taxpayer whose income increases from 200% to 300% of the FPL may see a reduction in their PTC due to the higher applicable percentage. Practitioners should advise clients on healthcare enrollment strategies, particularly if their income places them near the upper limit of PTC eligibility. For example, a taxpayer at 400% of the FPL will contribute 9.50% of their income toward the second-lowest-cost silver plan premium in 2027, which may still result in a significant PTC depending on the premium in their area.

Compliance and documentation requirements are heightened by the complexity of the PTC framework. Practitioners must ensure that clients maintain accurate records of their income, coverage, and advance premium tax credits received during 2027. Failure to reconcile the APTC with the actual PTC can result in repayment obligations or audit risks. The IRS has increased scrutiny of PTC claims, particularly in cases where taxpayers fail to reconcile APTC or misreport income. Practitioners should document their calculations and advise clients on the importance of timely and accurate reporting.

The Broader Impact: Aligning Policy with Healthcare Realities

The adjustments in Rev. Proc. 2026-26 reflect a broader effort to ensure that the PTC remains a viable tool for making healthcare affordable in an era of rising premiums. By indexing the applicable percentage table and required contribution percentage to healthcare-specific inflation metrics, the IRS is aligning the PTC framework with the realities of the healthcare market. This approach ensures that the PTC continues to fulfill its intended purpose: to provide financial assistance to individuals and families who need it most.

For practitioners, these adjustments underscore the importance of staying informed about changes in healthcare policy and the IRS’s evolving guidance. The PTC is a dynamic component of the tax code, and its effectiveness depends on the IRS’s ability to adapt to changing economic conditions. By understanding the indexing methodology, the statutory framework of § 36B, and the practical implications for taxpayers, practitioners can provide valuable guidance to their clients and help them navigate the complexities of the PTC framework.

IRS Designates Charitable Remainder Annuity Trust Transactions as Listed Transactions

The IRS finalized regulations identifying certain Charitable Remainder Annuity Trust transactions as listed transactions under § 6011, a designation reserved for abusive tax avoidance schemes. Issued as Treasury Decision 10051, these regulations take effect July 9, 2026, and impose disclosure obligations on material advisors and participants while explicitly excluding charitable remaindermen from these requirements. The move underscores the IRS’s ongoing campaign against abusive charitable trust arrangements, particularly those exploiting the tier structure governing CRAT distributions under § 664.

The final regulations implement the IRS’s authority under § 6011 to designate reportable transactions as listed transactions when they are determined to have a potential for tax avoidance or evasion. Section 6707A further reinforces this authority by defining listed transactions and imposing penalties for non-disclosure. The IRS’s focus on CRATs reflects broader concerns about the misuse of charitable remainder trusts to generate artificial tax deductions or defer capital gains, often through complex tier structures that misapply § 664’s distribution rules.

While the regulations do not alter the fundamental tax treatment of legitimate CRATs, they target specific abusive structures that misinterpret the tier system under § 664(b), which governs the tax character of distributions from CRATs. The IRS emphasized that organizations serving solely as charitable remaindermen—those designated to receive the trust’s remainder interest—are not considered participants in the listed transaction and are thus exempt from disclosure requirements and related penalties. This distinction preserves the charitable purpose of CRATs while curbing abusive tax planning strategies. The effective date of July 9, 2026, provides taxpayers and advisors with limited time to review their arrangements and ensure compliance with the new disclosure obligations.

CRAT Listed Transactions: IRS Targets Abusive Tier Structure Interpretations

The IRS’s designation of certain Charitable Remainder Annuity Trust transactions as listed transactions under Treasury Decision 10051 marks a significant escalation in its crackdown on abusive tax shelters. This action specifically targets a misinterpretation of the tier structure under § 664(b), where taxpayers improperly characterize annuity payments as ordinary income rather than distributions from the trust’s capital gain and ordinary income tiers. The IRS’s move follows years of scrutiny over aggressive CRAT strategies that exploit regulatory ambiguities to defer or eliminate capital gains taxes, aligning with broader enforcement trends against sophisticated tax avoidance schemes.

The rule, codified at § 1.6011-15(b), identifies CRAT transactions as listed transactions if they involve a grantor funding the trust with appreciated property, followed by the trustee selling the property and using sale proceeds to purchase an annuity. The abusive element lies in how beneficiaries report the annuity payments on their tax returns. Instead of treating the payments as distributions from the trust’s tiered income structure—where distributions are taxed first as ordinary income, then capital gains, and finally corpus—they improperly claim the payments are entirely taxable as ordinary income under § 72, thereby avoiding capital gains taxation. This misapplication of § 664(b)’s tier system is the crux of the IRS’s enforcement focus.

Section 664(b) establishes a four-tier system for taxing distributions from CRATs. The first tier consists of ordinary income such as interest, dividends, and short-term capital gains, followed by capital gains including long-term gains taxed at preferential rates, then tax-exempt income, and finally corpus which is a non-taxable return of principal. The IRS argues that taxpayers in these abusive arrangements are exploiting this tier system by artificially recharacterizing capital gain distributions as ordinary income through the annuity mechanism. The agency contends that such transactions lack economic substance beyond tax avoidance, as the annuity payments are funded by the sale of appreciated assets, and the tax benefits are disproportionate to the charitable purpose of the trust.

Public comments on the proposed regulations revealed sharp divisions among practitioners. Some tax professionals argued that the IRS’s interpretation of § 664(b) was overly restrictive, asserting that CRATs are legitimate estate planning tools when structured correctly. They pointed to Revenue Ruling 2020-23, which clarified the 10% remainder test for CRATs, as evidence that the IRS had already addressed potential abuses through existing guidance. Others, however, supported the IRS’s position, noting that the abusive transactions in question were designed solely to exploit the tier system for tax deferral. The IRS ultimately rejected the criticism, emphasizing that the listed transaction designation applies only to arrangements that misapply § 664(b) in a manner inconsistent with its legislative purpose.

The implications for material advisors, participants, and charitable remainders are substantial. Material advisors who promote or facilitate these abusive CRAT transactions face penalties under § 6707A, which imposes a penalty of up to $200,000 per transaction for failure to disclose listed transactions. Participants—defined as taxpayers whose tax returns reflect the tax consequences of the listed transaction—must file Form 8886 to disclose their involvement, even if the transaction is later determined to be non-abusive. Charitable remainders, however, are explicitly exempt from these requirements under § 1.6011-4(c)(3)(i)(A), as they are not considered participants solely by virtue of receiving the trust’s remainder interest. This distinction preserves the charitable purpose of CRATs while targeting the abusive tax planning strategies.

The IRS’s action is part of a broader enforcement campaign against tax shelters, including syndicated conservation easements and micro-captive insurance arrangements. The agency’s aggressive stance reflects its commitment to curbing abusive tax planning, particularly in the wake of legislative changes like the Tax Cuts and Jobs Act of 2017, which expanded the IRS’s authority to challenge sophisticated tax avoidance schemes. Practitioners must now carefully review existing CRAT arrangements to ensure compliance with the new disclosure obligations, as the effective date of July 9, 2026, provides limited time for retroactive adjustments. Failure to comply could result in substantial penalties and heightened audit risk, underscoring the need for meticulous documentation and adherence to the IRS’s evolving guidance on charitable remainder trusts.

IRS Clarifies Life Insurance Contract Exchanges and Reportable Policy Sales

The IRS issued final regulations under § 101 and § 6050Y to clarify the application of the transfer for valuable consideration rules and associated information reporting requirements for life insurance contract exchanges and reportable policy sales. These regulations, issued as TD 10052, take effect on July 9, 2026, and address longstanding ambiguities in how life insurance transactions are taxed and reported. The guidance builds upon the 2019 final regulations under § 6050Y, which first introduced reporting obligations for life insurance sales, but left critical questions unanswered regarding § 1035 exchanges and corporate reorganizations.

The IRS’s intervention follows years of industry uncertainty and aggressive tax planning strategies involving life insurance contracts, particularly in the context of life settlements and corporate transactions. The final regulations aim to curb abusive interpretations of the transfer for valuable consideration rules while providing clarity for taxpayers and issuers navigating complex life insurance transactions. For practitioners, the regulations introduce new compliance obligations, particularly in documenting exchanges and reporting sales, which will require immediate attention given the mid-year effective date.

The regulations directly impact holders of life insurance contracts, issuers, and material advisors involved in exchanges or sales, as well as beneficiaries receiving death benefits. The IRS’s focus on these transactions reflects broader enforcement priorities targeting perceived loopholes in life insurance taxation, including the use of § 1035 exchanges to reset tax attributes and corporate reorganizations to transfer policies without triggering taxable events. Practitioners must now reassess existing strategies to ensure compliance with the updated rules, particularly in light of the retroactive effective date.

Section 1035 Exchanges: IRS Reverses Course on Transfer for Value Rule

The IRS’s finalization of TD 10052 marks a seismic shift in the taxation of life insurance policy exchanges under § 1035, particularly as it pertains to the transfer-for-value rule under § 101(a)(2) and its interplay with death benefit excludability. This regulatory overhaul, rooted in the 2019 final regulations and refined through 2023’s proposed and final iterations, dismantles longstanding interpretations that had provided taxpayers with significant planning opportunities. The IRS’s reversal—explicitly rejecting prior guidance—demands immediate reassessment of life insurance transaction strategies, especially those involving corporate reorganizations and policy exchanges structured to reset tax attributes.

The transfer-for-value rule, codified in § 101(a)(2), operates as a critical exception to the general exclusion of life insurance death benefits from gross income under § 101(a)(1). Under this rule, if a life insurance policy is transferred for valuable consideration, the death benefit becomes taxable to the extent it exceeds the transferee’s basis in the policy. The IRS’s 2019 final regulations under § 1.101-1(b)(2)(iv) had carved out a narrow exception for certain § 1035 exchanges, allowing non-recognition of gain or loss while preserving the death benefit exclusion—provided the exchange did not involve a transfer for value. However, the 2023 proposed and final regulations under TD 10052 explicitly dismantle this exception, treating § 1035 exchanges as reportable policy sales subject to § 6050Y reporting requirements and potentially triggering transfer-for-value taxation.

The IRS’s volte-face stems from a broader enforcement agenda targeting perceived abuses in life insurance taxation, particularly the use of § 1035 exchanges to reset tax attributes and corporate reorganizations to transfer policies without triggering taxable events. Public comments submitted during the 2023 rulemaking process highlighted concerns over the IRS’s interpretation of state insurable interest laws and the treatment of boot in exchanges. The IRS ultimately rejected these concerns, affirming that § 1035 exchanges involving transfers for value—even in corporate reorganizations—do not qualify for the death benefit exclusion under § 101(a)(1). The agency’s response underscored its view that such transactions, when structured to avoid tax, undermine the integrity of the tax system, particularly in light of the growing life settlement market and the increasing sophistication of policy transfer strategies.

The implications for practitioners are profound. First, the retroactive effective date of TD 10052—applicable to exchanges occurring after December 31, 2017—means that taxpayers who relied on the 2019 regulations may face unexpected tax liabilities for prior transactions. The IRS’s position that § 1035 exchanges do not qualify for the death benefit exclusion unless they meet the stringent exceptions of § 101(a)(2)—such as transfers to the insured, a partner of the insured, or a corporation in which the insured is a shareholder—eliminates a key planning tool for estate and business succession strategies. Second, the new information reporting requirements under § 1.6050Y-3(h) impose additional compliance burdens. Unlike the 2019 final regulations, which did not explicitly require reporting for § 1035 exchanges, TD 10052 mandates that issuers and acquirers file Forms 1099-LS and 1099-SB for reportable policy sales, including those structured as exchanges. This reporting regime aligns § 1035 exchanges with the broader framework of § 6050Y, ensuring that the IRS can track transactions that may otherwise escape scrutiny.

The IRS’s treatment of boot in § 1035 exchanges further complicates compliance. Under prior guidance, partial exchanges involving boot were generally treated as taxable to the extent of the boot received. TD 10052 extends this principle, clarifying that any consideration received in an exchange—whether cash, cancellation of indebtedness, or other property—triggers immediate recognition of gain to the extent it exceeds the policyholder’s basis. This interpretation aligns with the IRS’s broader crackdown on abusive tax shelters, where boot is used to extract value from policies without triggering immediate taxation. Practitioners must now carefully structure exchanges to minimize boot or structure transactions to qualify for the limited exceptions under § 101(a)(2).

The IRS’s response to public comments on state insurable interest laws is particularly noteworthy. Commenters argued that state laws governing insurable interest should influence the federal tax treatment of policy transfers, particularly in corporate reorganizations where policies are transferred as part of a merger or acquisition. The IRS rejected this argument, emphasizing that federal tax law governs the transfer-for-value rule and that state law compliance does not immunize transactions from § 101(a)(2) taxation. This stance underscores the IRS’s willingness to disregard state law nuances in favor of a uniform federal approach, a trend that aligns with its broader enforcement priorities in life insurance taxation.

For practitioners, the key takeaway is the need for immediate action. Transactions structured under the 2019 regulations may no longer be viable, and taxpayers must reassess existing strategies to ensure compliance with the new rules. This includes reviewing corporate reorganization agreements, life insurance trust documents, and policy exchange arrangements to identify potential transfer-for-value triggers. Additionally, practitioners must familiarize themselves with the new reporting requirements under § 6050Y, particularly the deadlines for filing Forms 1099-LS and 1099-SB. Failure to comply with these reporting obligations can result in penalties under § 6721 and § 6722, compounding the tax risks associated with non-compliant transactions.

The IRS’s reversal on § 1035 exchanges reflects a broader shift in its approach to life insurance taxation, one that prioritizes enforcement over taxpayer flexibility. As the agency continues to refine its guidance, practitioners must remain vigilant, ensuring that their clients’ transactions comply with the evolving regulatory landscape. The retroactive application of TD 10052 serves as a stark reminder of the IRS’s willingness to challenge long-standing interpretations, leaving little room for error in an area where the stakes—both tax and reputational—are exceptionally high.

De Minimis Exception for Corporate Reorganizations: IRS Limits Scope

The IRS finalized guidance under § 1.101-1(c)(2)(v) that significantly narrows the scope of the de minimis exception for ordinary course mergers and acquisitions, a move that reverberates through the corporate reorganization landscape. This exception, historically a safe harbor for small-scale transactions, now faces stricter thresholds and active trade or business requirements that practitioners must navigate with precision. The IRS’s decision to limit this exception comes amid broader scrutiny of corporate reorganizations, particularly those involving life insurance contracts, where the agency has aggressively reinterpreted transfer for value rules under § 101(a)(2).

The de minimis exception under § 1.101-1(c)(2)(v) allows taxpayers to avoid the transfer for value rule when the consideration received in exchange for a life insurance policy does not exceed 5% of the policy’s face value. This exception was designed to accommodate routine corporate transactions where life insurance policies are transferred incidentally, such as in mergers or acquisitions, without triggering taxable income under the transfer for value rule. However, the IRS has now clarified that this exception applies only to transactions where the policy is transferred as part of an active trade or business, and the consideration does not exceed the 5% threshold. The active trade or business requirement ensures that the exception is not exploited for passive or speculative transactions, aligning with the IRS’s broader enforcement priorities in life insurance taxation.

The IRS’s decision to limit the de minimis exception follows public comments requesting an expansion of the rule to cover a wider range of transactions. Practitioners had argued that the 5% threshold was overly restrictive, particularly for small businesses engaged in routine corporate reorganizations where life insurance policies are transferred as part of larger asset deals. The IRS rejected these arguments, stating that the existing framework already provides sufficient flexibility for legitimate transactions while preventing abuse. The agency emphasized that the active trade or business requirement is essential to prevent the exception from being used to shield taxable gains in transactions that lack a clear business purpose.

The implications of this guidance are particularly acute for C corporations and other entities involved in acquisitive transactions. Companies that rely on life insurance policies for executive compensation, key person insurance, or estate planning must now conduct thorough due diligence to ensure that any transfers of policies in the context of reorganizations comply with the revised de minimis exception. Failure to do so could result in unexpected tax liabilities, as the IRS has made clear that it will not tolerate attempts to circumvent the transfer for value rule through loosely structured transactions. The IRS’s retroactive application of these rules, as seen in TD 10052, underscores the importance of compliance, leaving little room for error in an area where the stakes—both tax and reputational—are exceptionally high.

This development is part of a broader trend in IRS guidance on corporate reorganizations and life insurance taxation, one that prioritizes enforcement over taxpayer flexibility. As the agency continues to refine its rules, practitioners must remain vigilant, ensuring that their clients’ transactions comply with the evolving regulatory landscape. The IRS’s willingness to challenge long-standing interpretations, as demonstrated in TD 10052, serves as a stark reminder that corporate reorganizations involving life insurance policies are under heightened scrutiny.

Information Reporting for Life Insurance Contracts: Simplified but Still Complex

The IRS’s final regulations under § 1.6050Y-3(h) and related provisions mark a deliberate pivot from the agency’s earlier, more rigid stance on information reporting for life insurance contracts—one that reflects both statutory mandates and the IRS’s acknowledgment of administrative burdens. This evolution traces back to the 2019 final regulations under § 6050Y, which introduced sweeping reporting obligations for reportable policy sales and exchanges of life insurance contracts. The 2019 rules, while comprehensive, imposed substantial compliance burdens on issuers, acquirers, and brokers, prompting widespread criticism from industry stakeholders and taxpayers alike. The IRS’s response, as reflected in the 2026 final regulations, represents a calibrated retreat from that initial rigidity, incorporating public feedback to streamline reporting while preserving the core enforcement objectives of § 6050Y.

The 2019 final regulations under § 6050Y established a three-pronged reporting framework: issuers were required to file Form 1099-LS for reportable policy sales, acquirers had to file Form 1099-SB to report their investment in the contract, and brokers facilitating such transactions were subject to parallel obligations. The regulations also introduced stringent deadlines—issuers had to file Form 1099-LS within 30 days of the sale, and acquirers had to furnish payee statements to sellers within the same timeframe. The IRS’s rationale was clear: to combat abusive life settlement transactions and enforce the transfer-for-value rule under § 101(a)(2), which taxes death benefits when policies are sold or transferred for consideration unless an exception applies. The 2019 rules were designed to create a robust audit trail, enabling the IRS to identify transactions that might otherwise escape scrutiny, particularly those involving third-party investors purchasing policies from unrelated parties.

Public comments on the 2019 regulations were voluminous and sharply critical. Industry groups, including the American Council of Life Insurers and the National Association of Insurance Commissioners, argued that the reporting requirements were overly burdensome, particularly for small issuers and brokers. They contended that the 30-day filing deadline was impractical, given the complexity of tracking policy sales and the administrative overhead required to generate accurate Forms 1099-LS and 1099-SB. Taxpayers and practitioners also raised concerns about the potential for duplicate reporting, as some transactions might trigger multiple filing obligations under § 6050Y and other provisions, such as § 1035 exchanges. The IRS’s response, as articulated in the 2026 final regulations, reflects a careful balancing act—retaining the statutory framework while easing administrative burdens where possible.

The most significant change in the 2026 final regulations is the IRS’s decision to allow issuers to use Form 1099-R, rather than Form 1099-LS, for reporting certain reportable policy sales, particularly those involving § 1035 exchanges of reportable policy sales contracts. Section 1035 exchanges, which allow for tax-free swaps of life insurance policies or annuity contracts, have long been a cornerstone of life insurance planning. However, the IRS’s 2019 regulations did not explicitly address whether such exchanges could trigger reporting obligations under § 6050Y. The 2026 regulations clarify that issuers may report § 1035 exchanges involving reportable policy sales contracts on Form 1099-R, provided they use a new distribution code—specifically, Code “Q” for reportable policy sales under § 1035 exchanges. This change simplifies compliance for issuers, who can now leverage existing reporting infrastructure for § 1035 exchanges rather than developing separate processes for Forms 1099-LS.

The IRS’s decision to permit the use of Form 1099-R for § 1035 exchanges is not merely a procedural tweak; it reflects a broader recognition of the administrative challenges posed by the 2019 regulations. The IRS acknowledged that requiring separate forms for reportable policy sales transactions and § 1035 exchanges would create unnecessary complexity, particularly for issuers who already report § 1035 exchanges on Form 1099-R. By allowing the use of a new distribution code, the IRS reduces the compliance burden on issuers while maintaining the integrity of the reporting system. This approach aligns with the agency’s broader efforts to streamline information reporting, as evidenced by its recent revisions to other tax forms and schedules.

The 2026 final regulations also address the treatment of life insurance issuers and policyholders in the context of reportable policy sales. Under the 2019 rules, issuers were required to file Form 1099-LS for any sale of a life insurance contract where the acquirer had no substantial family, business, or financial relationship with the insured. The IRS’s 2026 guidance clarifies that issuers are not required to file Form 1099-LS for sales that qualify as § 1035 exchanges, provided the exchange meets the requirements of § 1035(a). This clarification is critical for policyholders engaged in tax-free exchanges, as it eliminates the risk of duplicate reporting and reduces the administrative burden on both issuers and taxpayers. The IRS also provides transition relief for issuers who have already filed Forms 1099-LS for § 1035 exchanges in prior years, allowing them to correct any errors without penalty.

For life insurance issuers, the 2026 final regulations represent a pragmatic shift in the IRS’s enforcement posture. The agency has historically taken a hardline stance on information reporting, particularly in cases involving abusive tax shelters or transactions designed to circumvent the transfer-for-value rule. However, the IRS’s willingness to adapt its reporting requirements in response to public feedback underscores its recognition of the practical challenges faced by industry participants. This shift is consistent with the agency’s broader efforts to reduce administrative burdens under the Paperwork Reduction Act, which requires federal agencies to minimize the paperwork burden on the public while ensuring the collection of necessary information.

The Paperwork Reduction Act has played a significant role in shaping the IRS’s approach to information reporting for life insurance contracts. Under the PRA, the IRS must obtain approval from the Office of Management and Budget before implementing new reporting requirements, and it must publish notices in the Federal Register soliciting public comment. The 2019 regulations under § 6050Y underwent extensive PRA review, with the IRS receiving numerous comments from industry groups and taxpayers. The 2026 final regulations reflect the IRS’s response to those comments, incorporating changes designed to reduce the compliance burden while preserving the statutory objectives of § 6050Y. The IRS’s PRA compliance is particularly noteworthy in the context of life insurance reporting, where the agency has historically faced criticism for imposing overly burdensome requirements.

The implications of the 2026 final regulations for life insurance issuers and policyholders are substantial. For issuers, the ability to use Form 1099-R for § 1035 exchanges simplifies reporting and reduces the risk of errors. The new distribution code for reportable policy sales under § 1035 exchanges ensures that such transactions are properly tracked by the IRS, enabling the agency to identify potential abuses of the transfer-for-value rule. For policyholders, the regulations provide greater clarity on the reporting obligations associated with life insurance transactions, reducing the risk of unintended tax consequences. The transition relief offered by the IRS further mitigates the burden on taxpayers who may have filed incorrect or duplicate forms in prior years.

However, despite these simplifications, the reporting requirements for life insurance contracts remain complex. The IRS’s final regulations under § 1.6050Y-3(h) do not eliminate the core obligations of § 6050Y; they merely streamline the reporting process in certain contexts. Issuers and policyholders must still navigate a labyrinth of rules governing reportable policy sales, § 1035 exchanges, and the transfer-for-value rule. The IRS’s use of Form 1099-R for § 1035 exchanges is a step in the right direction, but it does not address all the challenges posed by the 2019 regulations. For example, the IRS has not clarified whether other types of life insurance transactions—such as viatical settlements or accelerated death benefit transactions—are subject to reporting under § 6050Y. Practitioners must remain vigilant, ensuring that their clients’ transactions comply with the evolving regulatory landscape.

The IRS’s willingness to adapt its reporting requirements for life insurance contracts is a testament to its recognition of the practical challenges faced by industry participants. However, the agency’s enforcement posture remains stringent, particularly in cases involving abusive tax shelters or transactions designed to circumvent the transfer-for-value rule. The 2026 final regulations represent a pragmatic shift in the IRS’s approach, but they do not signal a relaxation of its broader enforcement objectives. Practitioners must continue to monitor IRS guidance and court rulings to ensure compliance with the ever-changing regulatory landscape. The IRS’s efforts to simplify reporting for life insurance contracts are a step in the right direction, but the complexity of the underlying rules means that practitioners must remain vigilant in their advisory roles.

Winners and Losers: How the New Regulations Impact Taxpayers and Practitioners

The IRS’s final regulations—spanning Rev. Proc. 2026-26, TD 10051, and TD 10052—represent a deliberate tightening of enforcement in high-stakes areas while introducing modest simplifications in others. The net effect is a regulatory environment where compliance precision is rewarded, but those relying on aggressive tax strategies face heightened risk. Practitioners must now recalibrate their advisory frameworks to align with the IRS’s clarified rules on charitable remainder annuity trusts, life insurance exchanges, and de minimis reorganization exceptions, all while preparing for expanded reporting obligations under § 6050Y.

The clearest winners are taxpayers with compliant CRATs and life insurance holders engaging in legitimate § 1035 exchanges. For CRATs, the IRS’s designation of abusive tier structures as listed transactions under § 1.6011-15 removes ambiguity for well-structured trusts that adhere to the 10% remainder test under § 664(d)(1)(C). The IRS explicitly excluded charitable remaindermen from liability under § 4965, shielding tax-exempt organizations from penalties tied to improper trust interpretations. Life insurance policyholders benefit from the IRS’s reversal on the transfer-for-value rule in § 1035 exchanges, where the final regulations clarify that direct transfers between policies for the same insured do not trigger taxable income under § 101(a)(2), provided the exchange complies with the statutory requirements of § 1035. This provides certainty for estate planners and individuals restructuring policies to reduce costs or improve coverage.

Practitioners specializing in estate planning and tax-exempt organizations also emerge as relative winners. The IRS’s decision to carve out charitable remaindermen from listed transaction participation under § 1.6011-15’s paragraph (d) reduces administrative burdens for nonprofit advisors and trustees. Similarly, the de minimis exception for corporate reorganizations under § 368, while narrowed, still offers relief for small-scale transactions that do not trigger material tax consequences. Advisors who have invested in systems to track reportable policy sales under § 6050Y will find their compliance infrastructure already aligned with the finalized rules, avoiding costly retroactive adjustments.

Conversely, the life insurance industry and promoters of abusive CRAT structures face significant losses. The IRS’s aggressive stance on CRATs—designating transactions that use tiered distributions to manipulate capital gain recognition as listed transactions—deprives promoters of a lucrative loophole. The IRS’s definition in § 1.6011-15(b)(5) targets arrangements where beneficiaries improperly characterize annuity payments as § 72 annuity income rather than trust distributions under § 664(b), effectively eliminating the tax deferral benefits of these abusive structures. Life insurance issuers must now contend with expanded § 6050Y reporting requirements, which mandate the filing of Forms 1099-LS and 1099-SB for reportable policy sales, adding operational complexity and potential liability for non-compliance. The IRS’s clarification that indirect acquisitions trigger reporting obligations under § 6050Y(c) further ensnares intermediaries in the life settlement market, increasing costs and reducing transactional efficiency.

Charitable organizations, while shielded from direct liability in CRATs, face indirect operational challenges. The IRS’s heightened scrutiny of CRAT compliance may deter donors from funding trusts that do not meet the 10% remainder test, potentially reducing charitable contributions. Additionally, the IRS’s refusal to extend the de minimis exception for corporate reorganizations beyond truly minor transactions limits the flexibility of nonprofits and other tax-exempt entities in restructuring assets without triggering taxable events.

For taxpayers and practitioners navigating the Premium Tax Credit adjustments in Rev. Proc. 2026-26, the winners are those who qualify for expanded subsidies under § 36B, particularly lower-income households in states that have not expanded Medicaid. The IRS’s inflation-adjusted percentages for 2027 lower the percentage of income required for premium contributions, making ACA coverage more affordable. However, the complexity of reconciling advance premium tax credits on Form 8962 remains a compliance burden, disproportionately affecting low-income filers who may lack access to professional tax assistance.

Practitioners must act swiftly to update internal compliance systems. Firms should implement automated tracking for § 6050Y reporting, ensuring that Forms 1099-LS and 1099-SB are filed within 30 days of reportable policy sales. Advisors handling CRATs must verify that distributions comply with the tier structure under § 664(b) and document the 10% remainder test to avoid listed transaction penalties. For life insurance exchanges, practitioners should confirm that § 1035 exchanges are structured as direct transfers to preserve tax-free treatment under § 101. Additionally, material advisors must file Form 8918 for any reportable transactions, including those involving CRATs or life settlements, to avoid § 6707A penalties.

The IRS’s final regulations do not signal a relaxation of enforcement but rather a strategic consolidation of its audit priorities. Practitioners who proactively align their practices with these rules will mitigate risk, while those clinging to outdated interpretations or aggressive tax strategies face escalating exposure. The IRS’s pragmatic adjustments—such as the CRAT carve-outs and simplified § 6050Y reporting—offer limited relief, but the overarching trend is toward stricter compliance and greater transparency. In this environment, the distinction between winners and losers will hinge on the ability to adapt to the IRS’s evolving expectations.